Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

combination therapy

  • You have access
    Nanomedicine-based combination therapies for overcoming temozolomide resistance in glioblastomas
    Chun Wang, Qiushi Li, Jian Xiao and Yang Liu
    Cancer Biology & Medicine May 2023, 20 (5) 325-343; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0761
  • You have access
    Current state and future of co-inhibitory immune checkpoints for the treatment of glioblastoma
    Shaoping Shen, Ling Chen, Jialin Liu, Lin Yang, Mengna Zhang, Lingxiong Wang, Rong Zhang, Yasushi Uemura, Qiyan Wu, Xinguang Yu and Tianyi Liu
    Cancer Biology & Medicine August 2020, 17 (3) 555-568; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0027
  • You have access
    Low-frequency HIFU induced cancer immunotherapy: tempting challenges and potential opportunities
    Guilian Shi, Mingchuan Zhong, Fuli Ye and Xiaoming Zhang
    Cancer Biology & Medicine November 2019, 16 (4) 714-728; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0232
  • You have access
    Synergistic inhibition of MEK and reciprocal feedback networks for targeted intervention in malignancy
    Yanan Li, Qingrong Dong and Yukun Cui
    Cancer Biology & Medicine August 2019, 16 (3) 415-434; DOI: https://doi.org/10.20892/j.issn.2095-3941.2019.0137
  • You have access
    Nanotechnology-based combination therapy for overcoming multidrug-resistant cancer
    Meng Zhang, Ergang Liu, Yanna Cui and Yongzhuo Huang
    Cancer Biology & Medicine August 2017, 14 (3) 212-227; DOI: https://doi.org/10.20892/j.issn.2095-3941.2017.0054
  • You have access
    Advances in drug delivery system for platinum agents based combination therapy
    Xiang Kang, Hai-Hua Xiao, Hai-Qin Song, Xia-Bin Jing, Le-San Yan and Ruo-Gu Qi
    Cancer Biology & Medicine December 2015, 12 (4) 362-374; DOI: https://doi.org/10.7497/j.issn.2095-3941.2015.0063

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2025 Cancer Biology & Medicine

Powered by HighWire